Open-Label Extension of the Dose Finding Study (DSC/08/2357/36) in Patients With Poly Juvenile Idiopathic Arthritis
Status:
Terminated
Trial end date:
2014-01-27
Target enrollment:
Participant gender:
Summary
Primary Objective of the study:
the purpose of this extension study was to determine the safety of Givinostat in a long term
treatment of patients who participated in DSC/08/2357/36 study with good results (clinical
benefit at least pediACR30 response);